Le Lézard
Classified in: Health
Subjects: NPT, SVY, WOM, BFA, BLK, DEI

Removing Barriers: Susan G. Komen® Launches Stand for H.E.R - A Health Equity Revolution Impact Report


The report outlines the organization's comprehensive approach for achieving breast health equity in the Black community.

DALLAS, Jan. 30, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, has launched the Stand for H.E.R. ? A Health Equity Revolution Breast Cancer Impact Report. This transformative report not only exposes the stark breast cancer health disparities faced by Black women in the United States, but also details Komen's concerted efforts to help dismantle these barriers and foster community relationships to create systemic change.

Susan G. Komen has launched the Stand for H.E.R. ? A Health Equity Revolution Breast Cancer Impact Report.

Breast cancer is the most prevalent cancer among Black women in the U.S., and alarming statistics reveal that Black women in the U.S. are about 40% more likely than white women to die of breast cancer. Black women are also diagnosed younger and are more likely to be diagnosed with more aggressive forms of the disease than white women. Aside from differences in tumor biology, factors such as implicit bias, substandard care and systemic racism contribute significantly to this discrepancy.

"Black women continue to face significant barriers to breast cancer care, regardless of what age they are, if they're insured or where they live," said Paula Schneider, president and CEO of Susan G. Komen. "As highlighted in our report, the Stand for H.E.R. program creates a scalable model to support marginalized populations experiencing breast health inequities. It calls on us to create a world where everyone has access to high-quality care and the same chance of survival."

Building on decades of work in health equity, Komen launched Stand for H.E.R. ? A Health Equity Revolution in 2021, a program designed to remove barriers to high-quality breast care for Black women across the U.S. using five key health equity drivers of change: Patient Support, Education, Workforce Development, Research, and Public Policy and Advocacy. The Stand for H.E.R. Impact Report showcases Komen's progress and commitment to achieving health equity for the Black community through these key drivers:

Patient Support: Bridging the Gap with Individualized Care and Financial Assistance

Education: Empowering through Knowledge and Community

Workforce Development: Shaping the Future of Healthcare Leadership

Research: Advancing Health Equity through Research

Public Policy and Advocacy: Supporting Voices for Systemic Change

While Komen's Stand for H.E.R. program has made a significant impact, the battle is far from over. To learn more about these efforts through the true stories of women who have been impacted by this work, read the Stand for H.E.R. Breast Cancer Impact Report.

For more information on Komen's efforts to close the breast cancer health equity gap for the Black community and make quality care available to all, visit www.komen.org/standforher.

About Susan G. Komen®

Susan G. Komen® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Media Contact
[email protected] 

SOURCE Susan G. Komen


These press releases may also interest you

at 03:01
'Textbook of Tinnitus' is a comprehensive textbook that describes tinnitus, how it is caused, and state-of-the art interventions such as Lenire.Top-ranked tinnitus expert authors of the Textbook of Tinnitus state that Lenire's clinical trial results...

at 03:00
In a significant stride towards preventing antimicrobial resistance, Smart Blood Analytics Swiss proudly announces the attainment of EU-MDR (European Medical Device Regulation)1 certification for their VIRUS vs. BACTERIA Clinical Decision Support...

at 02:43
January-March 2024 Net sales, which for the quarter only included royalties, amounted to SEK 156 (520)Net earnings amounted to KSEK -2,946 (-51,658), where exchange rate effects of KSEK 21 358 (435) had a substantial impact.Earnings per share before...

at 02:27
Market Overview The Global Biometric Technologies Market is expected to grow at a compound annual growth rate (CAGR) of around 12% between 2024 and 2031, from an estimated USD 38 billion in 2023 to approximately USD 120 billion by 2031. Our study...

at 02:05
Locate Bio, a pioneering orthobiologics company, today announces the successful completion of an oversubscribed £9.2 million funding round from both new investors and existing investors, Mercia Ventures and BGF. The proceeds will fund a clinical...

at 02:05
Positive topline results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...



News published on and distributed by: